谷歌浏览器插件
订阅小程序
在清言上使用

Real-world Experience of Commercial Relmacabtagene Autoleucel (Relma-Cel) for Relapsed/refractory Central Nervous System Lymphoma: a Multicenter Retrospective Analysis of Patients in China

JOURNAL FOR IMMUNOTHERAPY OF CANCER(2024)

引用 0|浏览33
暂无评分
关键词
Chimeric antigen receptor - CAR,Central Nervous System Cancer,Combination therapy,Lymphoma,Immunotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要